Amniotic membrane extract eye drops for eye surface diseases.

Completed

• Conditions: The efficacy of amniotic membrane extract in the treatment of ocular surface diseases with inflammation and epithelial disorders.; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12610000014055
• Lead Sponsor: Zuguo Liu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-01-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

ocular surface diseases with epithelial disorders and inflammation

Exclusion Criteria

trichiasis, palpebral conjunctiva scar, limbal stem cell dificiency, corneal perforation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mean epithelialization time, the epithelialization is measured by fluorescein stainning under slit lamp examination[every other day during first week, then 2, 3 weeks, 1, 2, 3, 6, 12 months following treatment.]

Secondary Outcome Measures

Name	Time	Method
mean inflammation score[1, 2, 3 weeks, 1, 2, 3, 6, 12 months following treatment.]